Companies to co-promote newly-approved statin LIVALO in the U.S. market Lilly licenses LIVALO commercialization rights for Latin America INDIANAPOLIS and MONTGOMERY, Ala., Dec. 23 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY), Kowa Company, …
Biopharmaceuticals, Cardiology, Licensing
Eli Lilly, Kowa Pharmaceuticals, LIVALO, pitavastatin, hyperlipidemia

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement”
Leave a Comment